Case Study: A female patient presents with a case of pyoderma gangrenosum that fails multiple standard treatments.
In this article, we discuss the possibility of innate lymphocytes as therapeutic targets in rheumatic disease as described in Nature Reviews Rheumatology.
Doctors, remember that pain is subjective and may not fall easily into a grading system, writes Dr. Irina Litvin, a rheumatology fellow at SUNY Downstate in Brooklyn, N.Y.
Adalimumab for the treatment of noninfectious uveitis has advantages over no treatment or conventional treatment with steroid therapy.
Marijuana use is up as is concern over laced cannabis. Dr. Litvin shares her account of a patient self-medicating with a non-medical grade marijuana leading to negative outcomes.
Aggressive treatment early in rheumatoid arthritis is the accepted practice today. In this slideshow, Dr. Litvin reminds us of patients diagnosed in the pre-biologics era.
Rheumatologists face unique challenges not fully addressed in CMS' Quality Payment Program, says CSRO's Dr. Michael Schweitz. Dr. Schweitz addresses these challenges in this blog post.
Sometimes it’s not enough to ask "How are you feeling?” In this slideshow, we list eight communication pitfalls physicians should avoid.
Building a relationship with your patients is the first step to avoiding communication pitfalls, says Dr. Ellen M. Field of Bethlehem, Penn.
Global Healthy Living Foundation and CreakyJoints president and co-founder, Seth Ginsberg, cautions against extrapolation, but is optimistic about biosimilars.